Medtronic annual r&d spending
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Medtronic R&D Spending Growth & History (MDT)
Medtronic's r&d spending was $2.87B for fiscal 2026.
View full Medtronic company overviewMedtronic annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-04-24 | $2.87B | $141.0M | +5.16% |
| 2025 | 2025-04-25 | $2.73B | −$3.0M | −0.11% |
| 2024 | 2024-04-26 | $2.73B | $39.0M | +1.45% |
| 2023 | 2023-04-28 | $2.70B | −$50.0M | −1.82% |
| 2022 | 2022-04-29 | $2.75B | $253.0M | +10.15% |
| 2021 | 2021-04-30 | $2.49B | $162.0M | +6.95% |
| 2020 | 2020-04-24 | $2.33B | $1.0M | +0.04% |
| 2019 | 2019-04-26 | $2.33B | $74.0M | +3.28% |
| 2018 | 2018-04-27 | $2.26B | $63.0M | +2.87% |
| 2017 | 2017-04-28 | $2.19B | −$31.0M | −1.39% |
| 2016 | 2016-04-29 | $2.22B | $584.0M | +35.61% |
| 2015 | 2015-04-24 | $1.64B | $163.0M | +11.04% |
| 2014 | 2014-04-25 | $1.48B | −$80.0M | −5.14% |
| 2013 | 2013-04-26 | $1.56B | — | — |
Medtronic quarterly r&d spending
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
Q3.26
Q4.26
Q1.27
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-07-31 | $771.0M | $45.0M | +6.20% |
| Q4 2026 | 2026-04-24 | $671.0M | −$13.0M | −1.90% |
| Q3 2026 | 2026-01-31 | $722.0M | $47.0M | +6.96% |
| Q3 2026 | 2026-01-23 | $722.0M | $47.0M | +6.96% |
| Q2 2026 | 2025-10-24 | $754.0M | $57.0M | +8.18% |
| Q1 2026 | 2025-07-25 | $726.0M | $50.0M | +7.40% |
| Q4 2025 | 2025-04-25 | $684.0M | $10.0M | +1.48% |
| Q3 2025 | 2025-01-24 | $675.0M | −$20.0M | −2.88% |
| Q2 2025 | 2024-10-25 | $697.0M | −$1.0M | −0.14% |
| Q1 2025 | 2024-07-26 | $676.0M | $8.0M | +1.20% |
| Q4 2024 | 2024-04-26 | $674.0M | $34.0M | +5.31% |
| Q3 2024 | 2024-01-26 | $695.0M | $7.0M | +1.02% |
| Q2 2024 | 2023-10-27 | $698.0M | $22.0M | +3.25% |
| Q1 2024 | 2023-07-28 | $668.0M | −$24.0M | −3.47% |
| Q4 2023 | 2023-04-28 | $640.0M | −$12.0M | −1.84% |
| Q3 2023 | 2023-01-27 | $688.0M | $20.0M | +2.99% |
| Q2 2023 | 2022-10-28 | $676.0M | $0 | 0.00% |
| Q1 2023 | 2022-07-29 | $692.0M | −$58.0M | −7.73% |
| Q4 2022 | 2022-04-29 | $652.0M | $20.0M | +3.16% |
| Q3 2022 | 2022-01-28 | $668.0M | $67.0M | +11.15% |
| Q2 2022 | 2021-10-29 | $676.0M | $37.0M | +5.79% |
| Q1 2022 | 2021-07-30 | $750.0M | $129.0M | +20.77% |
| Q4 2021 | 2021-04-30 | $632.0M | $64.0M | +11.27% |
| Q3 2021 | 2021-01-29 | $601.0M | $28.0M | +4.89% |
| Q2 2021 | 2020-10-30 | $639.0M | $36.0M | +5.97% |
| Q1 2021 | 2020-07-31 | $621.0M | $34.0M | +5.79% |
| Q4 2020 | 2020-04-24 | $568.0M | −$26.0M | −4.38% |
| Q3 2020 | 2020-01-24 | $573.0M | $12.0M | +2.14% |
| Q2 2020 | 2019-10-25 | $603.0M | $13.0M | +2.20% |
| Q1 2020 | 2019-07-26 | $587.0M | $2.0M | +0.34% |
| Q4 2019 | 2019-04-26 | $594.0M | $2.0M | +0.34% |
| Q3 2019 | 2019-01-25 | $561.0M | $2.0M | +0.36% |
| Q2 2019 | 2018-10-26 | $590.0M | $34.0M | +6.12% |
| Q1 2019 | 2018-07-27 | $585.0M | $36.0M | +6.56% |
| Q4 2018 | 2018-04-27 | $592.0M | $39.0M | +7.05% |
| Q3 2018 | 2018-01-26 | $559.0M | $29.0M | +5.47% |
| Q2 2018 | 2017-10-27 | $556.0M | $2.0M | +0.36% |
| Q1 2018 | 2017-07-28 | $549.0M | −$7.0M | −1.26% |
| Q4 2017 | 2017-04-28 | $553.0M | −$22.0M | −3.83% |
| Q3 2017 | 2017-01-27 | $530.0M | −$16.0M | −2.93% |
| Q2 2017 | 2016-10-28 | $554.0M | $9.0M | +1.65% |
| Q1 2017 | 2016-07-29 | $556.0M | −$2.0M | −0.36% |
| Q4 2016 | 2016-04-29 | $575.0M | $47.0M | +8.90% |
| Q3 2016 | 2016-01-29 | $546.0M | $173.0M | +46.38% |
| Q2 2016 | 2015-10-30 | $545.0M | $171.0M | +45.72% |
| Q1 2016 | 2015-07-31 | $558.0M | $193.0M | +52.88% |
| Q4 2015 | 2015-04-24 | $528.0M | — | — |
| Q3 2015 | 2015-01-23 | $373.0M | — | — |
| Q2 2015 | 2014-10-24 | $374.0M | — | — |
| Q1 2015 | 2014-07-25 | $365.0M | — | — |
Medtronic r&d spending trends
Over the last five fiscal years, Medtronic's r&d spending increased from $2.49B to $2.87B, a change of $380.0M. The latest reported quarter, Q1 2027, shows $771.0M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medtronic source filings ↗Community posts
Medtronic begins European clinical use of its Stealth AXiS surgical system
Medtronic ($MDT) announced the first European procedures using its Stealth AXiS surgical system, with more than 23 procedures performed across seven sites in Germany, the UK, Italy and Spain. The initial experience includes spinal surgery. ...